Non-Viral Nucleic Acid Delivery System for RNA Therapeutics

被引:4
|
作者
Liu, Lianxiao [1 ]
Zhou, Yiming [1 ]
Xu, Anqiu [1 ]
Wang, Chenglong [1 ]
Li, Ning [1 ]
Huang, Hongwei [1 ,2 ,3 ]
Zhang, Yuntao [4 ]
Yang, Xiaoming [4 ]
机构
[1] China Natl Biol Grp Virogin Biotech Shanghai Ltd, CNBG Virogin, Shanghai 201802, Peoples R China
[2] Virogin Biotech Shanghai Ltd, Shanghai 201802, Peoples R China
[3] Virogin Biotech Canada Ltd, Richmond, ON V6V1A8, Canada
[4] China Natl Biotech Grp CNBG, Beijing 100024, Peoples R China
关键词
drug delivery; gene therapy; nanotechnology; nucleic acid; vectors; RNA therapeutics; NEGATIVE BREAST-CANCER; LIPID NANOPARTICLES; DRUG-DELIVERY; MESSENGER-RNA; GENE DELIVERY; IN-VIVO; MEDIATED DELIVERY; SIRNA DELIVERY; ASIALOGLYCOPROTEIN RECEPTOR; TARGETED DELIVERY;
D O I
10.1002/adtp.202300005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nucleic acid drugs can treat diseases caused by defective or abnormal genes. Herein, the mechanism of non-viral vectors for nucleic acid drug delivery is described. This review introduce non-viral vectors for nucleic acid drug delivery, including the nucleic acid-carrier conjugate, proteins and peptides-based nanoparticles, polysaccharides, and other biological macromolecules-based nanoparticles consisting of lipid nanoparticles, synthetic polymers-based nanoparticles, inorganic nanoparticles, and organic-inorganic hybrid nanoparticles. Finally, the challenges and prospects of non-viral vectors for nucleic acid drug delivery are discussed.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Asymmetric cationic lipid based non-viral vectors for an efficient nucleic acid delivery
    Meka, Rakeshchandra R.
    Godeshala, Sudhakar
    Marepally, Srujan
    Thorat, Ketan
    Rachamalla, Hari Krishna Reddy
    Dhayani, Ashish
    Hiwale, Ankita
    Banerjee, Rajkumar
    Chaudhuri, Arabinda
    Vemula, Praveen Kumar
    RSC ADVANCES, 2016, 6 (81): : 77841 - 77848
  • [32] Methodologies to investigate intracellular barriers for nucleic acid delivery in non-viral gene therapy
    Vermeulen, Lotte M. P.
    Brans, Toon
    De Smedt, Stefaan C.
    Remaut, Katrien
    Braeckmans, Kevin
    NANO TODAY, 2018, 21 : 74 - 90
  • [33] Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases
    Jingjing Gao
    Ziting Xia
    Dilrasbonu Vohidova
    John Joseph
    James N.Luo
    Nitin Joshi
    Acta Pharmaceutica Sinica B, 2023, (04) : 1400 - 1428
  • [34] Non-viral nanovectors for gene delivery: factors that govern successful therapeutics
    Viola, Joana R.
    El-Andaloussi, Samir
    Oprea, Iulian I.
    Smith, C. I. Edvard
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (06) : 721 - 735
  • [35] Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases
    Gao, Jingjing
    Xia, Ziting
    Vohidova, Dilrasbonu
    Joseph, John
    Luo, James N.
    Joshi, Nitin
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (04) : 1400 - 1428
  • [36] Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications
    Shtykalova, Sofia
    Deviatkin, Dmitriy
    Freund, Svetlana
    Egorova, Anna
    Kiselev, Anton
    LIFE-BASEL, 2023, 13 (04):
  • [37] Non-viral delivery of RNA for therapeutic T cell engineering
    Berdecka, Dominika
    De Smedt, Stefaan C.
    De Vos, Winnok H.
    Braeckmans, Kevin
    Advanced Drug Delivery Reviews, 2024, 208
  • [38] Transient Non-Viral RNA Delivery Mediated by a Lentiviral Particle
    Bouille, Pascale
    Gayon, Regis
    Iche, Alexandra
    Duthoit, Christine
    Lamouroux, Lucille
    Pages, Jean-Christophe
    MOLECULAR THERAPY, 2016, 24 : S215 - S215
  • [39] Non-Viral RNA Delivery During Pregnancy: Opportunities and Challenges
    Chaudhary, Namit
    Newby, Alexandra N.
    Whitehead, Kathryn A.
    SMALL, 2024, 20 (41)
  • [40] Non-viral delivery of RNA for therapeutic T cell engineering
    Berdecka, Dominika
    Smedt, Stefaan C. De
    Vos, Winnok H. De
    Braeckmans, Kevin
    ADVANCED DRUG DELIVERY REVIEWS, 2024, 208